Postgraduate research opportunities The Influence of hybrid nanoparticle architecture on theranostic abilities in pancreatic cancer

Apply

Key facts

  • Opens: Thursday 13 January 2022
  • Number of places: 1
  • Duration: 3 years

Overview

Cancer nanomedicine is dominating modern healthcare. This project is an opportunity to contribute to the development of novel nanomedicine interventions for the targeted and triggered release of pharmaceuticals in pancreatic cancer.
Back to opportunity

Eligibility

Must have an undergraduate degree in a relevant discipline and satisfy the University minimum entry requirements for PhD study.

THE Awards 2019: UK University of the Year Winner
Back to opportunity

Project Details

We are looking to recruit a PhD student with a relevant chemical, pharmaceutical, biomedical science or bioengineering background to design and develop novel nanomedicine platforms for chemotherapy.

Hybrid iron oxide-gold nanoparticles have been shown to have great potential as theranostic agents for cancer therapy. The iron oxide core can be used for diagnostic imaging using MRI whilst the gold surface possesses unique optimal properties. When gold nanoparticles or nano-shells are exposed to laser irradiation, they both refract and absorb the light energy and rapidly convert it into heat. This can be exploited as a trigger for drug release [1,2].

The conformational shape of iron oxide and gold coating layer number has been shown to have a direct impact on physical qualities. This project will focus on the synthesis of iron oxide nanoparticles in rod and cube confirmation with additional coating with gold in a single and multi-layered approach. The physical properties and drug loading abilities will be assessed compared with spherical particles. And the potential for externally induced manipulation will be explored. Additionally, the use of multi-layered gold shells will be investigated to see whether this has an effect on the heating properties. Optimal parameters for drug delivery applications will also be determined. Finally, drugs will be delivered in a thermos-responsive manner and tested in pancreatic cancer cell lines and models.

Keywords: Nanomedicine, nanoparticle, photonics, drug delivery, pharmaceutics, nanochemistry, medicine, cancer, chemotherapy, formulation

References: [1] Oluwasanmi A, Al-Shakarchi W, Manzur A, Aldebasi MH, Elsini RS, Albusair MK, Haxton KJ, Curtis ADM, Hoskins C. 2017. Diels Alder-mediated release of gemcitabine from hybrid nanoparticles for enhanced pancreatic cancer therapy. J Control Release, vol. 266, 355-364. 

[2] Malekigorji M, Alfahad M, Kong Thoo Lin P, Jones S, Curtis A, Hoskins C. 2017. Thermally triggered theranostics for pancreatic cancer therapy. Nanoscale, vol. 9(34), 12735-12745.

Techniques used: Chemical synthesis, HPLC, FTIR, ICP, photon correlation spectroscopy, transmission electron microscopy, laser irradiation, biological testing in cancer models

Back to opportunity

Funding details

Self funding students only (students will be liable for their own tuition & bench fees as well as living costs).

Back to opportunity

Supervisors

Professor Hoskins

Professor Clare Hoskins

Pure and Applied Chemistry

View profile
Back to course

Apply

Please email Dr Clare Hoskins if you would like to apply for this opportunity, clare.hoskins@strath.ac.uk

Number of places: 1

To read how we process personal data, applicants can review our 'Privacy Notice for Student Applicants and Potential Applicants' on our Privacy notices' web page.

Pure and Applied Chemistry

Programme: Pure and Applied Chemistry

PhD
full-time
Start date: Oct 2023 - Sep 2024

Pure and Applied Chemistry

Programme: Pure and Applied Chemistry

PhD
part-time
Start date: Oct 2023 - Sep 2024